Literature DB >> 10595783

Use of the plasminogen activation system by microorganisms.

J L Coleman1, J L Benach.   

Abstract

The use of host-derived PAS components by invasive bacteria is an increasingly recognized mechanism for acquisition of extracellular proteolytic activity. This overview summarizes the pertinent contributions to this field and is divided into three parts: (1) the PAS, (2) the interaction of bacteria that produce their own plasminogen activators with the host's PAS, and (3) the interaction of bacteria that do not produce their own plasminogen activators but use plasminogen activators supplied by the host. The significance of these mechanisms in relation to the invasive potentials of the various organisms is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10595783     DOI: 10.1016/s0022-2143(99)90095-1

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  32 in total

1.  Cell surface antigens of Mycoplasma species bovine group 7 bind to and activate plasminogen.

Authors:  Kylie Bower; Steven P Djordjevic; Nicholas M Andronicos; Marie Ranson
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

2.  Enolase as a plasminogen binding protein in Leishmania mexicana.

Authors:  Gilmer Vanegas; Wilfredo Quiñones; Cesar Carrasco-López; Juan Luis Concepción; Fernando Albericio; Luisana Avilán
Journal:  Parasitol Res       Date:  2007-07-27       Impact factor: 2.289

3.  Streptococcus pneumoniae choline-binding protein E interaction with plasminogen/plasmin stimulates migration across the extracellular matrix.

Authors:  Cécile Attali; Cécile Frolet; Claire Durmort; Julien Offant; Thierry Vernet; Anne Marie Di Guilmi
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

4.  OmpL1 is an extracellular matrix- and plasminogen-interacting protein of Leptospira spp.

Authors:  Luis G V Fernandes; Monica L Vieira; Karin Kirchgatter; Ivy J Alves; Zenaide M de Morais; Silvio A Vasconcellos; Eliete C Romero; Ana L T O Nascimento
Journal:  Infect Immun       Date:  2012-07-16       Impact factor: 3.441

5.  Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory Lyme arthritis.

Authors:  Jameson T Crowley; Klemen Strle; Elise E Drouin; Annalisa Pianta; Sheila L Arvikar; Qi Wang; Catherine E Costello; Allen C Steere
Journal:  J Autoimmun       Date:  2016-02-26       Impact factor: 7.094

6.  Plasminogen binding by group A streptococcal isolates from a region of hyperendemicity for streptococcal skin infection and a high incidence of invasive infection.

Authors:  Fiona C McKay; Jason D McArthur; Martina L Sanderson-Smith; Sandra Gardam; Bart J Currie; Kadaba S Sriprakash; Peter K Fagan; Rebecca J Towers; Michael R Batzloff; Gursharan S Chhatwal; Marie Ranson; Mark J Walker
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Modulation of the Bacillus anthracis secretome by the immune inhibitor A1 protease.

Authors:  Kathryn J Pflughoeft; Michelle C Swick; David A Engler; Hye-Jeong Yeo; Theresa M Koehler
Journal:  J Bacteriol       Date:  2013-11-08       Impact factor: 3.490

8.  Reduced thrombin generation increases host susceptibility to group A streptococcal infection.

Authors:  Hongmin Sun; Xixi Wang; Jay L Degen; David Ginsburg
Journal:  Blood       Date:  2008-12-03       Impact factor: 22.113

9.  In vitro identification of novel plasminogen-binding receptors of the pathogen Leptospira interrogans.

Authors:  Monica L Vieira; Marina V Atzingen; Tatiane R Oliveira; Rosane Oliveira; Daniel M Andrade; Silvio A Vasconcellos; Ana L T O Nascimento
Journal:  PLoS One       Date:  2010-06-22       Impact factor: 3.240

10.  Surface-expressed enolase contributes to the pathogenesis of clinical isolate SSU of Aeromonas hydrophila.

Authors:  Jian Sha; Tatiana E Erova; Rebecca A Alyea; Shaofei Wang; Juan P Olano; Vijay Pancholi; Ashok K Chopra
Journal:  J Bacteriol       Date:  2009-03-06       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.